Cholangiokines: undervalued modulators in the hepatic microenvironment
暂无分享,去创建一个
[1] F. Tacke,et al. Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression , 2023, Hepatology.
[2] Chuanyong Guo,et al. The Gut Microbiome and Ferroptosis in MAFLD , 2022, Journal of clinical and translational hepatology.
[3] Hanyang Liu,et al. Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver? , 2022, Cells.
[4] Lee M. Tatham,et al. FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2 , 2022, Nature.
[5] H. Tilg,et al. Gut-liver axis: Pathophysiological concepts and clinical implications. , 2022, Cell metabolism.
[6] Huanming Yang,et al. Single-cell Stereo-seq reveals induced progenitor cells involved in axolotl brain regeneration , 2022, Science.
[7] N. Björkström. Immunobiology of the biliary tract system , 2022, Journal of hepatology.
[8] A. Lok,et al. Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice , 2022, Nature Communications.
[9] H. Benyamini,et al. Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL6 trans-signaling. , 2022, Journal of hepatology.
[10] Hong Liu,et al. The gut–liver axis in sepsis: interaction mechanisms and therapeutic potential , 2022, Critical Care.
[11] Jun Wang,et al. Cellular Homeostasis and Repair in the Biliary Tree. , 2022, Seminars in liver disease (Print).
[12] K. Kanetaka,et al. Helicobacter bilis infection induces oxidative stress in and enhances the proliferation of human cholangiocytes , 2022, Helicobacter.
[13] Yue Chen,et al. Mechanisms of ductular reaction in non-alcoholic steatohepatitis , 2022, World journal of gastroenterology.
[14] K. Nakao,et al. C‐X‐C motif chemokine ligand 1 induced by Hedgehog signaling promotes mouse extrahepatic bile duct repair after acute injury , 2022, Hepatology.
[15] F. Tacke,et al. Location, location, location — spatial insight into hepatic macrophage populations , 2022, Nature Reviews Gastroenterology & Hepatology.
[16] L. Ohno-Machado,et al. Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis , 2022, Scientific Reports.
[17] N. LaRusso,et al. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target , 2022, Seminars in Immunopathology.
[18] F. Tacke,et al. Macrophages in cholangiopathies , 2021, Current opinion in gastroenterology.
[19] C. Huttenhower,et al. Human gut bacteria produce TH17-modulating bile acid metabolites , 2021, bioRxiv.
[20] S. Chakraborty,et al. Biliary Epithelial Senescence in Liver Disease: There Will Be SASP , 2021, Frontiers in Molecular Biosciences.
[21] Mingyue Zhu,et al. IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma , 2021, Frontiers in Oncology.
[22] Shi‐Mei Zhuang,et al. Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis , 2021, Signal Transduction and Targeted Therapy.
[23] Xiaoling Xu,et al. Cullin3 deficiency shapes tumor microenvironment and promotes cholangiocarcinoma in liver-specific Smad4/Pten mutant mice , 2021, International journal of biological sciences.
[24] E. Witze,et al. Regulation of EGFR signalling by palmitoylation and its role in tumorigenesis , 2021, Open Biology.
[25] P. Tangkijvanich,et al. The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma , 2021, Cancer Gene Therapy.
[26] S. Macdonald,et al. Emerging therapeutic opportunities for integrin inhibitors , 2021, Nature reviews. Drug discovery.
[27] R. Bataller,et al. Ductular reaction promotes intrahepatic angiogenesis through Slit2–Roundabout 1 signaling , 2021, Hepatology.
[28] S. Glaser,et al. Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease , 2021, Cells.
[29] Jia Fan,et al. Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis , 2021, Journal for ImmunoTherapy of Cancer.
[30] E. Harris,et al. Pathophysiological Communication between Hepatocytes and Non-Parenchymal Cells in Liver Injury from NAFLD to Liver Fibrosis. , 2021, Advanced drug delivery reviews.
[31] Qi Zhang,et al. Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny , 2021, Gut.
[32] F. Tacke,et al. Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance , 2021, International journal of molecular sciences.
[33] F. Tacke,et al. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies , 2021, International journal of molecular sciences.
[34] R. Sandford,et al. The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis , 2021, Hepatology.
[35] G. Minuk,et al. Fibroblast Growth Factor 19 Induced Changes in Non-malignant Cholangiocytes , 2021, Journal of clinical and translational hepatology.
[36] S. Forbes,et al. Liver regeneration and inflammation: from fundamental science to clinical applications , 2021, Nature Reviews Molecular Cell Biology.
[37] Yasunori Sato,et al. Interferon-induced protein with tetratricopeptide repeats 3 may be a key factor in primary biliary cholangitis , 2021, Scientific Reports.
[38] Sooah Kim,et al. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications , 2021, The American journal of gastroenterology.
[39] M. Altfeld,et al. Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4+ T cells in primary sclerosing cholangitis , 2021, Journal of hepatology.
[40] K. Schuebel,et al. Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injury. , 2021, The Journal of clinical investigation.
[41] K. Tsuneyama,et al. Ursodeoxycholic acid impairs liver‐infiltrating T‐cell chemotaxis through IFN‐γ and CX3CL1 production in primary biliary cholangitis , 2021, European journal of immunology.
[42] J. Boyer,et al. Bile formation and Secretion: An update. , 2021, Journal of hepatology.
[43] Yi Zhao,et al. Imbalance of TGF-β1/BMP-7 Pathways Induced by M2-polarized Macrophages Promotes Hepatocellular Carcinoma Aggressiveness. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.
[44] R. Fiorotto,et al. New insights on the role of vascular endothelial growth factor in biliary pathophysiology , 2021, JHEP reports : innovation in hepatology.
[45] Aurélie Beaufrère,et al. Combined hepatocellular-cholangiocarcinoma: An update. , 2021, Journal of hepatology.
[46] N. LaRusso,et al. Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the Mdr2-/- mouse , 2021, JHEP reports : innovation in hepatology.
[47] J. Crawford,et al. Post–COVID-19 Cholangiopathy: A Novel Entity , 2021, The American journal of gastroenterology.
[48] A. Mullen,et al. Our emerging understanding of the roles of long non-coding RNAs in normal liver function, disease, and malignancy , 2020, JHEP reports : innovation in hepatology.
[49] Bo Li,et al. A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia , 2020, Pediatric Surgery International.
[50] V. Shah,et al. Epigenomic Evaluation of Cholangiocyte TGFβ Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis. , 2020, Gastroenterology.
[51] F. Tacke,et al. Deciphering the Immune Microenvironment on A Single Archival Formalin-Fixed Paraffin-Embedded Tissue Section by An Immediately Implementable Multiplex Fluorescence Immunostaining Protocol , 2020, Cancers.
[52] G. Michalopoulos,et al. Liver regeneration: biological and pathological mechanisms and implications , 2020, Nature Reviews Gastroenterology & Hepatology.
[53] P. Ohashi,et al. The Roles of CD8+ T Cell Subsets in Antitumor Immunity. , 2020, Trends in cell biology.
[54] N. LaRusso,et al. Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[55] Yuan Zhang,et al. Single cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma. , 2020, Journal of hepatology.
[56] A. Benedetti,et al. Gut–Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology , 2020, Cells.
[57] A. Franke,et al. Monocytes as Potential Mediators of Pathogen‐Induced T‐Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC) , 2020, Hepatology.
[58] W. Zhou,et al. TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB‐EGF Expression and Proteolytic Cleavage , 2019, Hepatology.
[59] G. Gores,et al. The Spectrum of Reactive Cholangiocytes in Primary Sclerosing Cholangitis , 2019, Hepatology.
[60] Runping Liu,et al. Cholangiocyte‐Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis , 2019, Hepatology.
[61] J. Gingold,et al. Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma. , 2019, Trends in molecular medicine.
[62] L. Fabris,et al. Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early‐stage primary biliary cholangitis , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[63] V. Mazzi. Mig chemokine in primary biliary cirrhosis. , 2019, La Clinica terapeutica.
[64] L. Fabris,et al. The tumour microenvironment and immune milieu of cholangiocarcinoma , 2019, Liver international : official journal of the International Association for the Study of the Liver.
[65] S. Cockell,et al. High‐throughput sequencing identifies aetiology‐dependent differences in ductular reaction in human chronic liver disease , 2019, The Journal of pathology.
[66] F. Tacke,et al. Liver Macrophages: Old Dogmas and New Insights , 2019, Hepatology communications.
[67] Jacquelyn O. Russell,et al. Hepatocyte‐Specific β‐catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate into Hepatocytes , 2019, The FASEB Journal.
[68] G. Gores,et al. Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances , 2019, Hepatology.
[69] S. Forbes,et al. Hepatocyte‐Specific β‐Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes , 2019, Hepatology.
[70] S. Glaser,et al. Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances , 2018, Hepatology.
[71] A. Tanaka,et al. Pathogen infections and primary biliary cholangitis , 2018, Clinical and experimental immunology.
[72] G. Gores,et al. Cholangiocyte pathobiology , 2019, Nature Reviews Gastroenterology & Hepatology.
[73] Gary D Bader,et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations , 2018, Nature Communications.
[74] A. Benedetti,et al. Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies , 2018, International journal of molecular sciences.
[75] P. Tam,et al. Cholangiopathies – Towards a molecular understanding , 2018, EBioMedicine.
[76] H. Larjava,et al. Integrin αvβ6: Structure, function and role in health and disease. , 2018, The international journal of biochemistry & cell biology.
[77] M. Demaria,et al. Hallmarks of Cellular Senescence. , 2018, Trends in cell biology.
[78] S. Glaser,et al. Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease. , 2018, Clinics and research in hepatology and gastroenterology.
[79] E. O'Duibhir,et al. Paracrine cellular senescence exacerbates biliary injury and impairs regeneration , 2018, Nature Communications.
[80] T. Chieochansin,et al. Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells , 2018, Human vaccines & immunotherapeutics.
[81] J. Pawlotsky,et al. Interleukins‐17 and 27 promote liver regeneration by sequentially inducing progenitor cell expansion and differentiation , 2018, Hepatology communications.
[82] G. Gores,et al. Targeting senescent cholangiocytes and activated fibroblasts with B‐cell lymphoma‐extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2−/−) mice , 2018, Hepatology.
[83] Soyoung Lee,et al. Senescence-associated reprogramming promotes cancer stemness , 2017, Nature.
[84] D. Gotthardt,et al. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[85] G. Kullak-Ublick,et al. Drug-induced bile duct injury. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[86] R. Fiorotto,et al. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[87] T. Luong,et al. Pathogenesis of biliary fibrosis. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[88] M. Marzioni,et al. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[89] R. Urtasun,et al. Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[90] R. Fiorotto,et al. The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[91] M. Croft,et al. TNF activity and T cells. , 2018, Cytokine.
[92] S. Glaser,et al. Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury. , 2017, The American journal of pathology.
[93] P. Xue,et al. Role of AP-2α and MAPK7 in the regulation of autocrine TGF-β/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma , 2017, Journal of Hematology & Oncology.
[94] C. Spirlí,et al. Emerging concepts in biliary repair and fibrosis. , 2017, American journal of physiology. Gastrointestinal and liver physiology.
[95] T. Tordjmann,et al. Bile acids and their receptors during liver regeneration: "Dangerous protectors". , 2017, Molecular aspects of medicine.
[96] Darjus F. Tschaharganeh,et al. Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS. , 2017, Cancer cell.
[97] F. Lund-Johansen,et al. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis. , 2017, Journal of hepatology.
[98] Wei-Yu Lu,et al. Cholangiocytes act as Facultative Liver Stem Cells during Impaired Hepatocyte Regeneration , 2017, Nature.
[99] Wei-Chung Cheng,et al. Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response , 2017, Scientific Reports.
[100] F. Tacke,et al. Liver macrophages in tissue homeostasis and disease , 2017, Nature Reviews Immunology.
[101] T. Karlsen,et al. Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes. , 2017, The American journal of pathology.
[102] R. Venkataramanan,et al. Drug Metabolism in the Liver. , 2017, Clinics in liver disease.
[103] T. D. de Assunção,et al. Regenerative Medicine and the Biliary Tree , 2017, Seminars in Liver Disease.
[104] F. Tacke,et al. Liver — guardian, modifier and target of sepsis , 2017, Nature Reviews Gastroenterology &Hepatology.
[105] P. Dijke,et al. Immunoregulation by members of the TGFβ superfamily , 2016, Nature Reviews Immunology.
[106] X. Wang,et al. Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression. , 2016, Cancer cell.
[107] H. Choi,et al. Biology of Cholangiocytes: From Bench to Bedside , 2016, Gut and liver.
[108] T. Karlsen,et al. Elevated interleukin‐8 in bile of patients with primary sclerosing cholangitis , 2016, Liver international : official journal of the International Association for the Study of the Liver.
[109] A. Franchitto,et al. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor‐β1 biliary secretion in mice , 2016, Hepatology.
[110] Q. Xia,et al. Role of Osteopontin in Liver Diseases , 2016, International journal of biological sciences.
[111] G. Carpino,et al. The hepatic, biliary, and pancreatic network of stem/progenitor cell niches in humans: A new reference frame for disease and regeneration , 2016, Hepatology.
[112] Stefan Rose-John,et al. IL-6 pathway in the liver: From physiopathology to therapy. , 2016, Journal of hepatology.
[113] D. Bobbala,et al. Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1. , 2016, Cytokine.
[114] B. Chassaing,et al. Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet–Induced Liver Disease , 2016, Cellular and molecular gastroenterology and hepatology.
[115] R. Takata,et al. Impact of serum Wisteria floribunda agglutinin positive Mac‐2‐binding protein and serum interferon‐γ‐inducible protein‐10 in primary biliary cirrhosis , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.
[116] P. Klenerman,et al. Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1 , 2016, Journal of hepatology.
[117] D. Schuppan,et al. Macrophage recruitment by fibrocystin‐defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis , 2016, Hepatology.
[118] Xiaochen Bo,et al. Influence of the Biliary System on Biliary Bacteria Revealed by Bacterial Communities of the Human Biliary and Upper Digestive Tracts , 2016, PloS one.
[119] Frank Tacke,et al. Immunology in the liver — from homeostasis to disease , 2016, Nature Reviews Gastroenterology &Hepatology.
[120] D. Schuppan,et al. Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis , 2016, Hepatology.
[121] J. Zhu,et al. In Sickness and in Health: The Relationships Between Bacteria and Bile in the Human Gut. , 2016, Advances in applied microbiology.
[122] T. Karlsen,et al. The biliary epithelium presents antigens to and activates natural killer T cells , 2015, Hepatology.
[123] D. Häussinger,et al. TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro , 2015, Gut.
[124] E. Scott,et al. Connective tissue growth factor and integrin αvβ6: A new pair of regulators critical for ductular reaction and biliary fibrosis in mice , 2015, Hepatology.
[125] Hongxin Ma,et al. Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages , 2015, Gut.
[126] K. Lindor,et al. Primary biliary cirrhosis , 2003, The Lancet.
[127] N. LaRusso,et al. The Cholangiopathies. , 2015, Mayo Clinic proceedings.
[128] John J. Cole,et al. HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia , 2014, Genes & development.
[129] Kosei Maemura,et al. Molecular mechanism of cholangiocarcinoma carcinogenesis , 2014, Journal of hepato-biliary-pancreatic sciences.
[130] R. Bataller,et al. The biliary epithelium gives rise to liver progenitor cells , 2014, Hepatology.
[131] H. Saya,et al. Tumor necrosis factor‐α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression , 2014, Journal of hepato-biliary-pancreatic sciences.
[132] V. Paradis,et al. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition. , 2014, Journal of hepatology.
[133] N. LaRusso,et al. Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis , 2014, Laboratory Investigation.
[134] A. Franchitto,et al. Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice. , 2014, Gastroenterology.
[135] N. LaRusso,et al. AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Cholangiocyte Senescence by Way of N-Ras Activation Is a Characteristic of Primary Sclerosing Cholangitis , 2014 .
[136] Anthony D. Schmitt,et al. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma , 2014, Hepatology.
[137] C. Desbois-Mouthon,et al. Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor , 2013, Hepatology.
[138] A. Franchitto,et al. Recent advances in the morphological and functional heterogeneity of the biliary epithelium , 2013, Experimental biology and medicine.
[139] N. LaRusso,et al. The dynamic biliary epithelia: molecules, pathways, and disease. , 2013, Journal of hepatology.
[140] S. Morini,et al. Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice , 2013, Gut.
[141] Y. Nakanuma,et al. Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia , 2012, Journal of Clinical Pathology.
[142] J. Dranoff,et al. Advances in cholangiocyte immunobiology. , 2012, American journal of physiology. Gastrointestinal and liver physiology.
[143] X. Yao,et al. Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma , 2012, OncoTargets and therapy.
[144] Hiroshi Kimura,et al. Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation. , 2012, Molecular cell.
[145] H. Koga,et al. Vandetanib, an Inhibitor of VEGF Receptor-2 and EGF Receptor, Suppresses Tumor Development and Improves Prognosis of Liver Cancer in Mice , 2012, Clinical Cancer Research.
[146] W. Haigh,et al. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. , 2012, Mutation research.
[147] D. Gouma,et al. The human gallbladder secretes fibroblast growth factor 19 into bile: Towards defining the role of fibroblast growth factor 19 in the enterobiliary tract , 2012, Hepatology.
[148] T. Berg,et al. Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[149] A. Gouw,et al. Ductular reactions in human liver: Diversity at the interface , 2011, Hepatology.
[150] P. Lescuyer,et al. A step further in the analysis of human bile proteome. , 2011, Journal of proteome research.
[151] Maylee Hsu,et al. Significance of periductal Langerhans cells and biliary epithelial cell‐derived macrophage inflammatory protein‐3α in the pathogenesis of primary biliary cirrhosis , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[152] N. LaRusso,et al. Opisthorchis viverrini excretory/secretory products induce toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte. , 2010, Parasitology international.
[153] Yasunori Sato,et al. Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis. , 2010, Journal of hepatology.
[154] R. Mancinelli,et al. Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation , 2010, Hepatology.
[155] A. Kimura,et al. IL‐6: Regulator of Treg/Th17 balance , 2010, European journal of immunology.
[156] R. Mancinelli,et al. Gastrointestinal , Hepatobiliary and Pancreatic Pathology After Damage of Large Bile Ducts by Gamma-Aminobutyric Acid , Small Ducts Replenish the Biliary Tree by Amplification of Calcium-Dependent Signaling and de Novo Acquisition of Large Cholangiocyte Phenotypes , 2010 .
[157] Guoku Hu,et al. miR-221 suppresses ICAM-1 translation and regulates interferon-gamma-induced ICAM-1 expression in human cholangiocytes. , 2010, American journal of physiology. Gastrointestinal and liver physiology.
[158] K. Isse,et al. Periductal interleukin‐17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis , 2009, Clinical and experimental immunology.
[159] I. McKillop,et al. Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma. , 2009, The Journal of surgical research.
[160] D. Gouma,et al. High expression of the bile salt‐homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis , 2009, Hepatology.
[161] R. Mancinelli,et al. Taurocholate Feeding to Bile Duct Ligated Rats Prevents Caffeic Acid-Induced Bile Duct Damage by Changes in Cholangiocyte VEGF Expression , 2009, Experimental biology and medicine.
[162] D. Wendum,et al. Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. , 2009, Gastroenterology.
[163] A. Franchitto,et al. Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[164] G. Soukup,et al. MicroRNA-513 Regulates B7-H1 Translation and Is Involved in IFN-γ-Induced B7-H1 Expression in Cholangiocytes12 , 2009, The Journal of Immunology.
[165] S. Ramaiah,et al. Review Pathophysiological Role of Osteopontin in Hepatic Inflammation, Toxicity, and Cancer , 2007 .
[166] H. Friess,et al. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. , 2008, Journal of hepatology.
[167] L. Boon,et al. Coculture of human liver macrophages and cholangiocytes leads to CD40‐dependent apoptosis and cytokine secretion , 2007, Hepatology.
[168] S. Glaser,et al. Cholangiocyte injury and ductopenic syndromes. , 2007, Seminars in liver disease.
[169] K. Isse,et al. IL‐8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[170] G. Michalopoulos,et al. Liver Regeneration , 1997, Journal of cellular physiology.
[171] Dimitris Kletsas,et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.
[172] R. Wells. Faculty Opinions recommendation of Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. , 2006 .
[173] F. Balkwill. TNF-α in promotion and progression of cancer , 2006, Cancer and Metastasis Reviews.
[174] A. Franchitto,et al. Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. , 2006, The American journal of pathology.
[175] K. Migita,et al. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL‐6 and IL‐8 via the TLR4‐NF‐κB and ‐MAPK signaling pathways , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[176] J. Dranoff,et al. Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[177] Hajime Isomoto,et al. Interleukin 6 upregulates myeloid cell leukemia‐1 expression through a STAT3 pathway in cholangiocarcinoma cells , 2005, Hepatology.
[178] A. Franchitto,et al. The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. , 2005, Journal of hepatology.
[179] K. Isse,et al. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts , 2005, Hepatology.
[180] T. Mcclanahan,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.
[181] J. Costerton,et al. Defense system in the biliary tract against bacterial infection , 1992, Digestive Diseases and Sciences.
[182] L. Trümper. From bench to bedside , 2005, Medizinische Klinik.
[183] T. Oda,et al. Inhibition of Jagged-mediated Notch signaling disrupts zebrafish biliary development and generates multi-organ defects compatible with an Alagille syndrome phenocopy , 2004, Development.
[184] S. Glaser,et al. Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. , 2004, Gastroenterology.
[185] T. Hirayama,et al. Peptide antibiotic human beta‐defensin‐1 and ‐2 contribute to antimicrobial defense of the intrahepatic biliary tree , 2004, Hepatology.
[186] R. Taub. Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.
[187] D. Seo,et al. Oxysterols from human bile induce apoptosis of canine gallbladder epithelial cells in monolayer culture. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[188] V. Luketic,et al. A Review of the Physiological and Immunological Functions of Biliary Epithelial Cells: Targets for Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis and Drug-induced Ductopenias , 2004, Clinical & developmental immunology.
[189] G. Gores,et al. Oxysterols induce cyclooxygenase‐2 expression in cholangiocytes: Implications for biliary tract carcinogenesis , 2004, Hepatology.
[190] N. LaRusso,et al. Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes. , 2003, Gastroenterology.
[191] E. Levy,et al. Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. , 2003, Life sciences.
[192] R. Hultcrantz,et al. The Myofibroblastic Conversion of Peribiliary Fibrogenic Cells Distinct from Hepatic Stellate Cells Is Stimulated by Platelet-Derived Growth Factor During Liver Fibrogenesis , 2003, Laboratory Investigation.
[193] T. Kawaguchi,et al. Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes. , 2003, Liver international : official journal of the International Association for the Study of the Liver.
[194] D. Adams,et al. The role of cholangiocytes in the development of chronic inflammatory liver disease. , 2002, Frontiers in bioscience : a journal and virtual library.
[195] D. Black,et al. Regulation of triacylglycerol and phospholipid trafficking by fatty acids in newborn swine enterocytes. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[196] S. Glaser,et al. Functional heterogeneity of cholangiocytes. , 2002, Seminars in liver disease.
[197] M. Ulaganathan,et al. Biliary epithelial trefoil peptide expression is increased in biliary diseases , 2002, Histopathology.
[198] D. Schuppan,et al. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. , 2001, The American journal of pathology.
[199] T. Patel,et al. Involvement of p38 mitogen‐activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line , 2001, Hepatology.
[200] C. Sempoux,et al. Drug and toxin‐induced bile duct disorders , 2000, Journal of gastroenterology and hepatology.
[201] J. Lunz,et al. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor β1, and activin a: Comparison of a cholangiocarcinoma cell line with primary cultures of non‐neoplastic biliary epithelial cells , 2000, Hepatology.
[202] U. Beuers,et al. Hepatobiliary transport. , 2000, Journal of hepatology.
[203] P. Beaune,et al. Phase I and Phase II drug‐metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium , 1999, Hepatology.
[204] H. Herbst,et al. Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. , 1999, Journal of hepatology.
[205] N. Fausto,et al. Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[206] G. Michalopoulos,et al. Interleukin‐6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type i ductular reaction in mice: Interactions between the periductal inflammatory and stromal cells and the biliary epithelium , 1998, Hepatology.
[207] S. Lowe,et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.
[208] K. Tanikawa,et al. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. , 1998, Journal of hepatology.
[209] James S Goydos,et al. Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker. , 1998, Annals of surgery.
[210] S. Milani,et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. , 1998, The American journal of pathology.
[211] Y. Nakanuma,et al. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[212] N. LaRusso,et al. The pathobiology of biliary epithelia , 2002, Hepatology.
[213] T. Schall,et al. Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.
[214] S. Glaser,et al. gamma-Interferon inhibits secretin-induced choleresis and cholangiocyte proliferation in a murine model of cirrhosis. , 1997, Journal of hepatology.
[215] D. Adams,et al. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. , 1997, Proceedings of the Association of American Physicians.
[216] D. Adams,et al. Inflammatory cytokines stimulate human biliary epithelial cells to express interleukin-8 and monocyte chemotactic protein-1. , 1997, Biochemical Society transactions.
[217] L. Pannarale,et al. Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphological study. , 1996, Gastroenterology.
[218] M. Harada,et al. Functional differences between hepatocytes and biliary epithelial cells in handling polymeric immunoglobulin A2 in humans, rats, and guinea pigs , 1996, Hepatology.
[219] N. LaRusso,et al. Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. , 1996, Gastroenterology.
[220] G. Michalopoulos,et al. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: Interleukin‐6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro , 1994, Hepatology.
[221] N. LaRusso,et al. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. , 1994, The American journal of physiology.
[222] K. Saito,et al. Lactoferrin and lysozyme in the intrahepatic bile duct of normal livers and hepatolithiasis. An immunohistochemical study. , 1992, Journal of hepatology.
[223] H. Stein,et al. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. , 1991, The American journal of pathology.
[224] D. Kemp. Inappropriate diagnosis of necrotizing arachnidism: Watch out Miss Muffet — but don't get paranoid , 1990, The Medical journal of Australia.
[225] W. Brown,et al. The role of the liver in translocation of IgA into the gastrointestinal tract. , 1989, Immunological investigations.
[226] L. Sarkozi,et al. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. , 1988, The Journal of clinical investigation.
[227] K. Johnson. An Update. , 1984, Journal of food protection.
[228] R. Elferink. Cholestasis , 2003, The Western journal of medicine.
[229] L. Hayflick,et al. The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.